Print

Oscient Pharmaceuticals Corporation (OSCI) Receives NASDAQ Letter Regarding Delay in Filing Form 10-Q  
5/26/2009 10:31:46 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) has received notification from the Listings Qualifications Department of The NASDAQ Stock Market LLC that since the Company has not filed its Form 10-Q for the period ended March 31, 2009, the Company is no longer in compliance with Marketplace Rule 5250(c)(1).
//-->